-
Professor Peng Hu: Active Antiviral Treatment Significantly Improves Prognosis for Patients with Indeterminate Chronic Hepatitis B
According to the World Health Organization, there are currently about 257 million chronic hepatitis B (CHB) patients worldwide, with approximately 70 million HBV (hepatitis B virus) carriers in China, making it one of the countries with a high prevalence of chronic HBV infection. Due to factors such as viral characteristics, immune status, and environmental influences,…
-
Exosome miRNAs Profiling in Serum and Prognostic Evaluation in Patients with Multiple Myeloma
In the rapidly advancing fields of hematology and oncology, understanding the intricate mechanisms of diseases like multiple myeloma (MM) is crucial for developing innovative treatment strategies. One such area of significant interest is the role of exosomal microRNAs (exo-miRNAs) in the tumor microenvironment and their potential as biomarkers for disease prognosis. The recent study led…
-
Heterogeneity analysis of the CEBPAdm AML based on bZIP region mutations
In the evolving landscape of hematology, a recent study led by Professor Jianxiang Wang from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, investigated the heterogeneity of double-mutated CEBPA (CEBPAdm) acute myeloid leukemia (AML). Analyzing 2211 newly diagnosed AML patients, the study found that 10.8%…
-
Immune Checkpoint Expression Patterns on T Cell Subsets in Light-Chain Amyloidosis: VISTA, PD-1, and TIGIT as Potential Therapeutic Targets
In the dynamic field of hematology and oncology, innovative treatments for systemic amyloid light chain (AL) amyloidosis are essential. Recent research, led by Professor Yangqiu Li from the Institute of Hematology, School of Medicine, Jinan University, explores immune checkpoint expression patterns in AL amyloidosis. This study investigates VISTA+, PD-1+, Tim-3+, and TIGIT+ T cells in…
-
Optimizing Antibiotic Dosage in Obese and Underweight Patients: Insights from Professor Wenxiang Huang ‘s Presentation at ESCMID Global 2024
From April 27th to 30th, 2024, the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024) took place in Barcelona, Spain, known as the “Pearl of the Iberian Peninsula.” ESCMID Global, formerly known as ECCMID, stands as one of the most influential international conferences in the field of infectious diseases. Often, clinical…
-
Professor Hongfei Duan：Advances in Diagnosis and Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease
Non-tuberculous mycobacteria (NTM) refers to all mycobacteria other than Mycobacterium tuberculosis and Mycobacterium leprae. NTM most commonly affect the lungs, causing NTM pulmonary disease (NTM-PD), which can even lead to disseminated disease in immunocompromised individuals. In recent years, with changes in the environment, updates in detection technology, and increased awareness among physicians, the incidence of…
-
🔬🧬 Innovative Insights into MRD Detection and Risk Stratification for Pediatric AML via ctDNA
In this enlightening interview, Professor Xiaofan Zhu discusses cutting-edge methods for MRD detection and risk stratification in pediatric AML, highlighting the promising role of ctDNA testing.
-
✨ Ordinary Yet Extraordinary: The Diverse Roles of Doctors in the Fight Against Disease 🌟 – An Interview with Professor Sheng Yan
✨ Ordinary Yet Extraordinary: The Diverse Roles of Doctors in the Fight Against Disease 🌟 – An Interview with Professor Sheng Yan
Connecting Medical Expertise through Media